CD4 and cancer: An increase in PIGC expression was positively correlated with the expression of Treg cells; these cells are a subtype of CD4+ T cells that suppress anti-self-immune responses (Schmetterer et al., 2012) which can inhibit the development of anti-tumor immunity, thereby hindering the immune surveillance of cancer and preventing effective anti-tumor immune responses in tumor-bearing hosts.